Chargement en cours...

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation

Acute myeloid leukemia (AML) is a malignancy of uncontrolled proliferation of immature myeloid blasts characterized by clonal evolution and genetic heterogeneity. FMS-like tyrosine kinase 3 (FLT3) mutations occur in up to a third of AML cases and are associated with highly proliferative disease, sho...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Hematol
Auteurs principaux: Chew, Serena, Mackey, Melissa C., Jabbour, Elias
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7271272/
https://ncbi.nlm.nih.gov/pubmed/32547718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720930614
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!